<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: We recently reported that <z:mp ids='MP_0005039'>hypoxia</z:mp>-inducible factor 1alpha (HIF-1alpha), HIF-2alpha and cyclooxygenase 2 naked DNA induced <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> in a rat indirect bypass model </plain></SENT>
<SENT sid="1" pm="."><plain>In this work, we investigated whether the collateral circulation induced by HIF-1alpha DNA affected the <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: We utilized a rat encephalomyosynangiosis (EMS) model and inoculated HIF-1alpha DNA onto the brain surface </plain></SENT>
<SENT sid="3" pm="."><plain>These treatments were performed before the <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> occurred </plain></SENT>
<SENT sid="4" pm="."><plain>We thereafter performed middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> on the fifth or tenth day after EMS </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: A histological section treated with HIF-1alpha DNA for 10 days showed a well-developed collateral circulation (p&lt;0.05) and a reduction in the infarction volume in comparison to the control DNA (p&lt;0.01) </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSION: These results suggest the feasibility of a novel approach for the treatment of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> via the development of therapeutic collateral circulation, in which neovascularization may be indirectly achieved using a transcriptional regulatory strategy </plain></SENT>
</text></document>